These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1623915)
1. Pharmacokinetics of diphemanil methylsulphate in healthy subjects. Vidal AM; Rey E; Pons G; Pello JY; d'Athis P; Olive G Eur J Clin Pharmacol; 1992; 42(6):689-91. PubMed ID: 1623915 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of diphemanil methylsulphate in infants. Vidal AM; Chéron G; Rey E; Pons G; d'Athis P; Olive G Eur J Clin Pharmacol; 1993; 45(1):89-91. PubMed ID: 8405036 [TBL] [Abstract][Full Text] [Related]
3. Dose linearity and steady state pharmacokinetics of the new antiparkinson agent budipine after oral administration. Bethke TH; Merz M; Zech K; Seiberling M; Hauschke D; Heinze H; Wurst W Int J Clin Pharmacol Ther; 2001 Jun; 39(6):259-64. PubMed ID: 11430634 [TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability, and pharmacokinetics of single oral doses of tofacitinib, a Janus kinase inhibitor, in healthy volunteers. Krishnaswami S; Boy M; Chow V; Chan G Clin Pharmacol Drug Dev; 2015 Mar; 4(2):83-8. PubMed ID: 27128212 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics of diphemanil methylsulfate in infants]. Chéron G; Vidal AM; Rey E; Pons G; d'Athis P; Olive G Arch Pediatr; 1994 Jan; 1(1):33-7. PubMed ID: 8087216 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of diphemanil methylsulphate in neonates and in premature infants. Pariente-Khayat A; Vidal AM; Cheron G; Vauzelle-Kervroedan F; D'Athis P; Rey E; Gouyon JB; Wood C; Olive G; Pons G Eur J Clin Pharmacol; 1996; 50(5):429-30. PubMed ID: 8839669 [No Abstract] [Full Text] [Related]
7. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects. Rohatagi S; Gillen M; Aubeneau M; Jan C; Pandit B; Jensen BK; Rhodes G Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113. Part III: Pharmacokinetics, metabolism, dose dependency and gender effect after single or repeated administration to human healthy volunteers. Duchêne P; Laneury JP; Tran G; Ladure P; Ollivier R; Buzas A; Merour JY; Houin G Arzneimittelforschung; 1999 Aug; 49(8):699-704. PubMed ID: 10483517 [TBL] [Abstract][Full Text] [Related]
9. Absorption, Metabolism, Excretion, and the Contribution of Intestinal Metabolism to the Oral Disposition of [14C]Cobimetinib, a MEK Inhibitor, in Humans. Takahashi RH; Choo EF; Ma S; Wong S; Halladay J; Deng Y; Rooney I; Gates M; Hop CE; Khojasteh SC; Dresser MJ; Musib L Drug Metab Dispos; 2016 Jan; 44(1):28-39. PubMed ID: 26451002 [TBL] [Abstract][Full Text] [Related]
10. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers. Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and metabolism of [3H]-pipethiaden in healthy volunteers. Plecitá Z; Spanĕl M; Ulc I; Rejŏlec V; Lapka R Eur J Drug Metab Pharmacokinet; 1992; 17(2):89-92. PubMed ID: 1425816 [TBL] [Abstract][Full Text] [Related]
12. Concurrent administration of donepezil HCl and theophylline: assessment of pharmacokinetic changes following multiple-dose administration in healthy volunteers. Tiseo PJ; Foley K; Friedhoff LT Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):35-9. PubMed ID: 9839764 [TBL] [Abstract][Full Text] [Related]
13. Metabolism and elimination of 14C-donepezil in healthy volunteers: a single-dose study. Tiseo PJ; Perdomo CA; Friedhoff LT Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):19-24. PubMed ID: 9839761 [TBL] [Abstract][Full Text] [Related]
14. Preclinical and clinical pharmacokinetics of pirmenol. Chang T Am J Cardiol; 1987 Jun; 59(16):15H-19H. PubMed ID: 2438922 [TBL] [Abstract][Full Text] [Related]
15. Single oral dose safety, tolerability, and pharmacokinetics of PNU-96391 in healthy volunteers. Rodríguez CA; Azie NE; Adams G; Donaldson K; Francom SF; Staton BA; Bombardt PA J Clin Pharmacol; 2004 Mar; 44(3):276-83. PubMed ID: 14973308 [TBL] [Abstract][Full Text] [Related]
16. Single- and multiple-dose mibefradil pharmacokinetics in normal and hypertensive subjects. Welker HA J Pharm Pharmacol; 1998 Sep; 50(9):983-7. PubMed ID: 9811158 [TBL] [Abstract][Full Text] [Related]
17. Altered pharmacokinetics of oral flecainide by cimetidine. Tjandra-Maga TB; van Hecken A; van Melle P; Verbesselt R; de Schepper PJ Br J Clin Pharmacol; 1986 Jul; 22(1):108-10. PubMed ID: 3741720 [TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics, metabolism, and clearance mechanisms of tofacitinib, a janus kinase inhibitor, in humans. Dowty ME; Lin J; Ryder TF; Wang W; Walker GS; Vaz A; Chan GL; Krishnaswami S; Prakash C Drug Metab Dispos; 2014 Apr; 42(4):759-73. PubMed ID: 24464803 [TBL] [Abstract][Full Text] [Related]
19. Effect of Piperine on the Metabolism and Pharmacokinetics of Carbamazepine in Healthy Volunteers. Bedada SK; Appani R; Boga PK Drug Res (Stuttg); 2017 Jan; 67(1):46-51. PubMed ID: 27776366 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of graded single doses of the novel antitussive compound vadocaine hydrochloride in healthy male volunteers. Karttunen P; Männistö PT; Tukiainen H; Uusitupa M; Nissinen E Arzneimittelforschung; 1988 Apr; 38(4A):635-8. PubMed ID: 3395402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]